Macrocyclics, Inc. (an AREVA Med company) announced today the launch of new
offices located in China, Japan, South Korea, and France. The production
laboratory remains based in Dallas, Texas, USA; however, Asian and French
customers will now have a local contact for placing orders and obtaining
technical information about all products and services available from
Macrocyclics, and the ability to communicate in their own language as well as
English.

To reach Macrocyclics in their new offices, please use the following:

Beijing, China Tokyo, Japan
Mrs. Carrie SONG Mr. Sebastien PAES
+86-150-1146-1640 +81-90-2620-5448
china@macrocyclics.com japan@macrocyclics.com

Seoul, South Korea Limoges, France
Mrs. Hye-Young PARK Mr. Remy DUREAU
+82-2-551-01-65 +33-6-46-42-45-65
southkorea@macrocyclics.com france@macrocyclics.com

Macrocyclics specializes in the manufacture of customized chelating agents
used in nuclear medicine and medical imaging. We also offer custom-made cGMP
products for use in clinical trials, bioconjugation services, and consulting
services that will help our customers select the proper isotopes for their
particular needs.

Please visit http://www.macrocyclics.com for detailed information.